Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGM-Guided Acarbose for Painful Diabetic Neuropathy
NCT07436585Phase 1Completed
- Sponsor
- Shifa International Hospital
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in diabetic peripheral neuropathy (DPN) comparing Acarbose with Placebo (2 arms). Primary endpoints: Daily pain area-under-the-curve at 4 weeks and Mean Amplitude of Glycemic Excursions at 4 weeks. Started Sep 2025; status: completed.
02
Drugs
acarbose
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07436585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07436585.